BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7314260)

  • 1. Estrogen and progesterone binding proteins in human colorectal cancer. A preliminary characterization of estradiol receptor.
    Sica V; Contieri E; Nola E; Bova R; Papaleo G; Puca GA
    Tumori; 1981 Aug; 67(4):307-14. PubMed ID: 7314260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and progesterone receptors in malignant gastrointestinal tumors.
    Sica V; Nola E; Contieri E; Bova R; Masucci MT; Medici N; Petrillo A; Weisz A; Molinari AM; Puca GA
    Cancer Res; 1984 Oct; 44(10):4670-4. PubMed ID: 6467220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor pattern of human colorectal neoplasms.
    Bojar H; Heim ME; Petzinna D; Staib W
    Anticancer Res; 1984; 4(3):129-32. PubMed ID: 6331798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptors in colorectal carcinoma.
    Dawson PM; Shousha S; Blair SD; Carter GD; Jones J; Alaghband-Zadeh J; Theodorou NA
    J Clin Pathol; 1990 Feb; 43(2):149-51. PubMed ID: 2180984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptors in gastric cancer.
    Tokunaga A; Nishi K; Matsukura N; Tanaka N; Onda M; Shirota A; Asano G; Hayashi K
    Cancer; 1986 Apr; 57(7):1376-9. PubMed ID: 3948119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
    Iino Y
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormone receptors in gastric cancer.
    Wu CW; Chi CW; Chang TJ; Lui WY; P'eng FK
    Cancer; 1990 Mar; 65(6):1396-400. PubMed ID: 2306686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
    Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K
    Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close correlation between progesterone receptor concentration and hormonal sensitivity in DMBA-induced mammary tumours of the rat.
    Mobbs BG
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):835-42. PubMed ID: 6409617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
    Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
    Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in gallbladder cancer.
    Nakamura S; Muro H; Suzuki S
    Jpn J Surg; 1989 Mar; 19(2):189-94. PubMed ID: 2657151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer.
    Korenaga D; Orita H; Maekawa S; Itasaka H; Ikeda T; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):78-83. PubMed ID: 9058124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
    Baker VA; Puddefoot JR; Marsigliante S; Barker S; Goode AW; Vinson GP
    Br J Cancer; 1992 Dec; 66(6):1083-7. PubMed ID: 1457348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.